Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

crazyjogger925 wrote: friday march 19,2020 pres

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155373
(Total Views: 497)
Posted On: 03/22/2020 11:15:24 AM
Posted By: blafarm
Re: crazyjogger925 #22620
crazyjogger925 wrote:

Quote:
friday march 19,2020 press release please note words" sickest covid-19 patients"



Press Release:
Quote:
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients.


crazyjogger925, not sure WHO you were responding to, or WHAT you were responding to -- but just wanted to shed a little light on the actual condition of those two patients as described by NP in the last call.

The Press Release quote includes the all-important qualifier: "their" -- which only means those are the sickest patients that they have -- but not the sickest patients that can be found with COVID-19.

NP stated that those two patients were NOT in later stage ARDS. Please see the excerpt below in which I have bolded meaningful text, added missing characters or words in [brackets] , and colored in red meaningLESS text.

And, of course, here is a link to the recording: https://www.youtube.com/watch?v=SPqa6F0rVXE

38:09 [Question] okay so Tony's asking how are the two
38:11 virus patients have the two virus
38:14 patients been diagnosed with a [A]RDS prior
38:18 to the injection or [h]as the disease
38:19 disease not progress[ed] that for you
38:24 [Answer]yes so these patients are severe lung
38:28 disease but it's not [AR]DSS and I
38:32 think you know again what we're trying
38:35 to do is break up this vicious cycle of
38:40 means of coming in producing cytokines
38:43 which bring in more immune cells which
38:45 produce more other kinds and break that
38:48 vicious cycle before they get here
38:51 reversible lung damage and so we're very
38:55 hopeful

It is likely that you already knew this, just thought it was worth making this distinction.


(3)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us